News

Alivexis to Present MOD-D Program at the 85th Annual Meeting of the Japanese Cancer Association- 09 September, 2026

Alivexis announces publication of a research article on its ground-breaking ModBind_dG™ simulation technology- 16 June, 2026

Alivexis and Ciconia Bioventures Announce Option Agreement for Incubation- 20 April, 2026

Alivexis and Astellas Pharma Inc. to Collaborate on Novel Drug Target- 26 March, 2026

Alivexis to Present at ACS Spring Conference- 18 March, 2026

Alivexis Announces Notice of U.S. Patent Registration for Novel Cathepsin C Inhibitor- 25 February, 2026

Alivexis and OHARA Pharmaceutical Co., Ltd. to Collaborate on Selected Drug Targets- 13 February, 2026

Alivexis Announces Receipt of Intention to Exercise Option Right from Astellas Pharma Inc. for Collaboration on Novel Drug Target- 02 September, 2025

Notice of Selection for the Ministry of Economy, Trade and Industry’s Domestic Generative AI Development Strengthening Project “GENIAC”- 15 July, 2025

Alivexis to Present at the 2025 BIO International Convention- 27 May, 2025

Next

Press & Media Contact

Latest Release